"In any illicit marketplaces, you're going to have some excellent uncertainty and uncertainty about what it's you might be consuming," suggests Munksgaard, who was not associated with the drug-testing study.Michael Forbes, CEO of Adastra, claimed in his First push release: “Damage reduction is usually a critically important and mainstream subject